Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
about
Protein kinase C signaling and cell cycle regulationQuercetin and ovarian cancer: An evaluation based on a systematic reviewThe diacylglycerol kinase α/atypical PKC/β1 integrin pathway in SDF-1α mammary carcinoma invasiveness.In vivo conditions to identify Prkci phosphorylation targets using the analog-sensitive kinase method in zebrafish.Synthesis and structure-activity relationships of 2-amino-3-carboxy-4-phenylthiophenes as novel atypical protein kinase C inhibitorsDiacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C ζ and ι from typical C1 domains.ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinomaProtein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.Atypical PKC-iota Controls Stem Cell Expansion via Regulation of the Notch Pathway.PKC in Regenerative Therapy: New Insights for Old Targets.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.c-Myc phosphorylation by PKCζ represses prostate tumorigenesis.PKCiota promotes ovarian tumor progression through deregulation of cyclin E.PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesisThe aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma.A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.Epithelial cell polarity, stem cells and cancer.Atypical protein kinase Cι as a human oncogene and therapeutic target.Protein kinase C and cancer: what we know and what we do not.Rewiring cell polarity signaling in cancer.Epidermal polarity genes in health and diseaseCopy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.PKCι depletion initiates mitotic slippage-induced senescence in glioblastomaThe epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma.Protein kinase C in cancer: The top five unanswered questions.Par6 is phosphorylated by aPKC to facilitate EMT.Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-quadruplex-binding small molecule.Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis
P2860
Q21131217-A6751E93-5245-487D-AB06-9B418F3B9F8EQ28071328-EF2D633D-F8F4-45F2-AABE-64AEE345462CQ33699564-5CA4F3E3-3DE6-489E-8BD3-C3B08F0B33A7Q34328511-9DEF2A88-AC1B-4280-887C-659C7FBC99F7Q34659495-E5A4B08D-4EB2-4489-B263-CF767FEB7742Q35027203-171A5C08-A42C-4049-8555-5B5FA7B0FF73Q35051418-A470A1BE-EE70-4C0D-9686-81EE7A5A3CD3Q35987724-03E39E72-16FF-413C-B09D-2E03EAC234E7Q36290989-5900F989-A5CA-44EA-95E6-A0FF094C7D71Q36376317-13516F4F-5F5D-40F5-B1AB-611FEDA8D063Q36510237-81A4D1D9-9CF8-4609-916C-E667E9502B7FQ36781982-30A55A55-1CDD-48DD-A3F6-CF1F08C815A5Q36869444-AF5A6C69-AD20-4BD0-985C-3F15D3ADDB83Q37520978-509AF466-5B9A-422C-B29B-8ADB15330DC0Q37680185-7B6A7D13-E202-4FCD-BDAE-B318AA7DF48AQ37741425-868FD187-E09E-492C-99CB-C2E7730A5898Q37968480-305046F1-D857-4841-96D1-0DF8FB9EE2FAQ38162656-2CE7B013-48EC-486D-BDAC-9AEFA739693AQ38171231-2DA8F45F-DE25-44CD-8C97-2918526C74DAQ38196268-3D473AE2-BE71-4A2F-8C8C-B38D363CF005Q38276290-3CEF1E38-98B5-40C7-AF65-F7372C587DABQ38390024-FBA03F71-638C-4F12-8B9B-67A31D6E06BEQ38707987-E657899C-8615-4B9D-AA6F-62DFAB44F9F8Q38882024-5A9D50A1-CE4A-44B2-ACC9-E52AD64CA331Q38956949-3E071FF2-0880-4C8F-BCE8-D0142A452F35Q38981503-7FA07312-E8D4-4698-B976-B1B378D75BC5Q39016188-956118AA-8CB6-437D-AD97-E19802F6AB2DQ39098659-5E20DB88-55B8-4587-8527-4FB7E386FC8DQ42065297-62C5C9B9-5468-49C1-87A5-55D2739737C7Q46874998-4BB9F570-AA9D-4A90-B49E-4B248089DB8EQ48195145-ED744288-E6F1-4125-AF81-682F56438495Q48678789-73A2AACF-E793-4289-9040-F00B30339EA4Q50962965-22865C9C-B1C4-4B10-A352-DB41CB919295Q58697716-3F0E0D3D-B764-46CF-BAB9-DF138F6E4A32
P2860
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@ast
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@en
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@nl
type
label
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@ast
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@en
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@nl
prefLabel
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@ast
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@en
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
@nl
P2860
P356
P1476
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer
@en
P2093
Alan P Fields
Nicole R Murray
P2860
P304
P356
10.1002/JCP.22463
P577
2011-04-01T00:00:00Z